Financial Ratios Dhanuka Agritech Limited NSE India S.E.
Equities
DHANUKA
INE435G01025
Agricultural Chemicals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,111.40 INR | +0.13% |
|
+2.18% | -5.80% |
| 18/12 | Dhanuka Agritech gets demand order for 16.4 million rupees | RE |
| 10/12 | Dhanuka Agritech got tax demand order for 1.21 billion rupees | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 15.38 | 12.66 | 12.3 | 12.04 | 13.39 | |||||
Return on Total Capital | 20.28 | 16.84 | 16.02 | 15.11 | 16.4 | |||||
Return On Equity % | 28 | 23.78 | 23.1 | 20.64 | 22.34 | |||||
Return on Common Equity | 28 | 23.78 | 23.1 | 20.64 | 22.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.78 | 36.45 | 34.39 | 39.03 | 40.1 | |||||
SG&A Margin | 9.47 | 9.15 | 8.28 | 9.92 | 9.42 | |||||
EBITDA Margin % | 19.02 | 17.44 | 16.42 | 18.32 | 20.01 | |||||
EBITA Margin % | 18.3 | 16.74 | 15.73 | 16.35 | 17.79 | |||||
EBIT Margin % | 18.3 | 16.74 | 15.73 | 16.35 | 17.79 | |||||
Income From Continuing Operations Margin % | 15.18 | 14.14 | 13.73 | 13.6 | 14.59 | |||||
Net Income Margin % | 15.18 | 14.14 | 13.73 | 13.6 | 14.59 | |||||
Net Avail. For Common Margin % | 15.18 | 14.14 | 13.73 | 13.6 | 14.59 | |||||
Normalized Net Income Margin | 12.16 | 11.16 | 10.18 | 10.98 | 11.79 | |||||
Levered Free Cash Flow Margin | 10.63 | 3.93 | 0.53 | -2.51 | 2.02 | |||||
Unlevered Free Cash Flow Margin | 10.75 | 4.07 | 0.65 | -2.4 | 2.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.34 | 1.21 | 1.25 | 1.18 | 1.2 | |||||
Fixed Assets Turnover | 9.52 | 7.82 | 6.51 | 5.28 | 5.94 | |||||
Receivables Turnover (Average Receivables) | 5.72 | 5.63 | 5.47 | 5.13 | 5.05 | |||||
Inventory Turnover (Average Inventory) | 3.17 | 2.92 | 3.22 | 2.81 | 2.99 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.11 | 3.14 | 3.01 | 3.69 | 3.29 | |||||
Quick Ratio | 1.74 | 1.89 | 1.8 | 1.97 | 1.88 | |||||
Operating Cash Flow to Current Liabilities | 0.84 | 0.34 | 0.46 | 0.48 | 0.75 | |||||
Days Sales Outstanding (Average Receivables) | 63.8 | 64.85 | 66.71 | 71.37 | 72.27 | |||||
Days Outstanding Inventory (Average Inventory) | 115.29 | 124.9 | 113.26 | 130.22 | 122.25 | |||||
Average Days Payable Outstanding | 41.77 | 50.43 | 56.33 | 51.08 | 42.54 | |||||
Cash Conversion Cycle (Average Days) | 137.32 | 139.33 | 123.65 | 150.51 | 151.99 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.08 | 3.31 | 3.16 | 2.15 | 5.29 | |||||
Total Debt / Total Capital | 5.73 | 3.21 | 3.06 | 2.1 | 5.03 | |||||
LT Debt/Equity | 4.56 | 2.85 | 2.42 | 1.79 | 1.91 | |||||
Long-Term Debt / Total Capital | 4.3 | 2.76 | 2.34 | 1.75 | 1.81 | |||||
Total Liabilities / Total Assets | 29.6 | 26.81 | 24.48 | 20.47 | 22.08 | |||||
EBIT / Interest Expense | 94.26 | 77.25 | 85.77 | 93.12 | 70.84 | |||||
EBITDA / Interest Expense | 99.74 | 82.2 | 91.29 | 106.13 | 80.83 | |||||
(EBITDA - Capex) / Interest Expense | 95.05 | 63.52 | 51.46 | 77.19 | 42.88 | |||||
Total Debt / EBITDA | 0.18 | 0.12 | 0.12 | 0.08 | 0.18 | |||||
Net Debt / EBITDA | -0.52 | -0.63 | -0.23 | -0.14 | -0.12 | |||||
Total Debt / (EBITDA - Capex) | 0.19 | 0.16 | 0.21 | 0.11 | 0.34 | |||||
Net Debt / (EBITDA - Capex) | -0.55 | -0.81 | -0.41 | -0.19 | -0.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.87 | 6.51 | 15.05 | 3.43 | 15.73 | |||||
Gross Profit, 1 Yr. Growth % | 28.35 | 2.77 | 8.55 | 17.37 | 18.9 | |||||
EBITDA, 1 Yr. Growth % | 56.9 | -2.35 | 7.77 | 15.38 | 26.41 | |||||
EBITA, 1 Yr. Growth % | 61.04 | -2.57 | 7.5 | 7.47 | 25.98 | |||||
EBIT, 1 Yr. Growth % | 61.04 | -2.57 | 7.5 | 7.47 | 25.98 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 48.96 | -0.79 | 11.78 | 2.39 | 24.2 | |||||
Net Income, 1 Yr. Growth % | 48.96 | -0.79 | 11.78 | 2.39 | 24.2 | |||||
Normalized Net Income, 1 Yr. Growth % | 55.52 | -2.23 | 4.92 | 11.57 | 24.3 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 50.16 | 0.53 | 12.27 | 4.19 | 24.96 | |||||
Accounts Receivable, 1 Yr. Growth % | 0.11 | 16.41 | 20.02 | 2.28 | 32.41 | |||||
Inventory, 1 Yr. Growth % | 18.27 | 17.49 | -0.61 | 21.1 | -4.58 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 45.32 | 19.04 | 54.1 | 10.37 | -3.81 | |||||
Total Assets, 1 Yr. Growth % | 21.33 | 16.02 | 7.1 | 12.37 | 13.99 | |||||
Tangible Book Value, 1 Yr. Growth % | 12.62 | 20.72 | 10.56 | 18.38 | -1.08 | |||||
Common Equity, 1 Yr. Growth % | 12.52 | 20.63 | 10.5 | 18.33 | 11.69 | |||||
Cash From Operations, 1 Yr. Growth % | 42.56 | -54.87 | 30.64 | -1.3 | 95.34 | |||||
Capital Expenditures, 1 Yr. Growth % | -8.04 | 374.13 | 107.58 | -28.06 | 117.15 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 14.74 | -60.57 | -84.69 | -587.78 | -193.3 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 15.17 | -59.68 | -82 | -483.66 | -205.15 | |||||
Dividend Per Share, 1 Yr. Growth % | -83.33 | 600 | -85.71 | 600 | -85.71 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 17.45 | 14.86 | 10.7 | 9.09 | 9.41 | |||||
Gross Profit, 2 Yr. CAGR % | 16.05 | 14.85 | 5.62 | 12.88 | 18.14 | |||||
EBITDA, 2 Yr. CAGR % | 34.57 | 23.78 | 2.86 | 11.51 | 20.77 | |||||
EBITA, 2 Yr. CAGR % | 37.76 | 25.26 | 2.63 | 7.49 | 16.36 | |||||
EBIT, 2 Yr. CAGR % | 37.76 | 25.26 | 2.63 | 7.49 | 16.36 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 36.76 | 21.57 | 5.31 | 6.98 | 12.77 | |||||
Net Income, 2 Yr. CAGR % | 36.76 | 21.57 | 5.31 | 6.98 | 12.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | 35.29 | 23.31 | 1.28 | 8.19 | 17.76 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 39.21 | 22.87 | 6.24 | 8.15 | 14.1 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.34 | 7.95 | 18.2 | 10.79 | 16.37 | |||||
Inventory, 2 Yr. CAGR % | 19.53 | 17.88 | 8.06 | 9.71 | 7.5 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 22.34 | 31.52 | 35.44 | 30.42 | 3.04 | |||||
Total Assets, 2 Yr. CAGR % | 16.36 | 18.64 | 11.47 | 9.7 | 13.18 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.43 | 16.6 | 15.53 | 14.4 | 8.21 | |||||
Common Equity, 2 Yr. CAGR % | 11.34 | 16.5 | 15.45 | 14.35 | 14.97 | |||||
Cash From Operations, 2 Yr. CAGR % | 316.86 | -19.79 | -23.22 | 13.56 | 38.86 | |||||
Capital Expenditures, 2 Yr. CAGR % | 44.11 | 108.81 | 213.72 | 22.2 | 24.99 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 450.88 | -32.74 | -75.25 | -13.58 | 113.33 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 488.86 | -31.85 | -72.86 | -16.89 | 100.86 | |||||
Dividend Per Share, 2 Yr. CAGR % | 82.57 | 8.01 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.96 | 13.68 | 14.93 | 8.22 | 11.26 | |||||
Gross Profit, 3 Yr. CAGR % | 9.39 | 11.45 | 12.71 | 9.4 | 14.85 | |||||
EBITDA, 3 Yr. CAGR % | 16.79 | 20.93 | 18.4 | 6.88 | 16.27 | |||||
EBITA, 3 Yr. CAGR % | 18.69 | 22.74 | 19.26 | 4.22 | 13.33 | |||||
EBIT, 3 Yr. CAGR % | 18.69 | 22.74 | 19.26 | 4.22 | 13.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.61 | 22.88 | 18.21 | 4.33 | 12.44 | |||||
Net Income, 3 Yr. CAGR % | 18.61 | 22.88 | 18.21 | 4.33 | 12.44 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.3 | 21.41 | 16.85 | 4.6 | 13.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.17 | 24.9 | 19.23 | 5.55 | 13.49 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.28 | 8.91 | 11.83 | 12.64 | 17.58 | |||||
Inventory, 3 Yr. CAGR % | 12.97 | 18.85 | 11.36 | 12.24 | 4.72 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.47 | 21.23 | 38.66 | 26.51 | 17.83 | |||||
Total Assets, 3 Yr. CAGR % | 11.19 | 16.25 | 14.66 | 11.77 | 11.11 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.01 | 14.45 | 14.55 | 16.47 | 8.99 | |||||
Common Equity, 3 Yr. CAGR % | 7.92 | 14.36 | 14.47 | 16.41 | 13.46 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.83 | 98.67 | -5.63 | -16.51 | 36.06 | |||||
Capital Expenditures, 3 Yr. CAGR % | 24.84 | 114.34 | 108.4 | 92.03 | 48.02 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 8.1 | 128.72 | -58.73 | -33.14 | -11.34 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 8.35 | 140.91 | -56.06 | -34.38 | -10.11 | |||||
Dividend Per Share, 3 Yr. CAGR % | -28.62 | 185.75 | -44.97 | 91.29 | -47.72 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.85 | 10.84 | 12.05 | 11.82 | 12.69 | |||||
Gross Profit, 5 Yr. CAGR % | 10.16 | 6.97 | 7.87 | 12.02 | 14.85 | |||||
EBITDA, 5 Yr. CAGR % | 13.48 | 8.73 | 11 | 17.19 | 19.34 | |||||
EBITA, 5 Yr. CAGR % | 13.54 | 9.8 | 11.99 | 16.53 | 18.09 | |||||
EBIT, 5 Yr. CAGR % | 13.54 | 9.8 | 11.99 | 16.53 | 18.09 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.43 | 11.38 | 13.1 | 16.26 | 16.01 | |||||
Net Income, 5 Yr. CAGR % | 14.43 | 11.38 | 13.1 | 16.26 | 16.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.85 | 9.5 | 11.17 | 15.94 | 17.21 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.77 | 12.97 | 14.39 | 17.91 | 17.15 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.49 | 8.97 | 10.27 | 9.66 | 13.63 | |||||
Inventory, 5 Yr. CAGR % | 11.36 | 5.59 | 10.98 | 15.1 | 9.8 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.61 | 8.69 | 19.85 | 24.82 | 23.13 | |||||
Total Assets, 5 Yr. CAGR % | 11.49 | 12.92 | 11.3 | 13.58 | 14.07 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.67 | 13.07 | 10.96 | 14.43 | 11.97 | |||||
Common Equity, 5 Yr. CAGR % | 10.63 | 12.98 | 10.88 | 14.35 | 14.67 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.59 | 10.56 | -0.21 | 58.84 | 10.14 | |||||
Capital Expenditures, 5 Yr. CAGR % | -16.77 | 24.58 | 80.48 | 71.2 | 69.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.41 | 38.82 | -40.06 | 55.42 | -20.38 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 22.37 | 38.29 | -37.73 | 57.84 | -19.3 | |||||
Dividend Per Share, 5 Yr. CAGR % | -21 | 87.76 | -18.32 | 87.76 | -30.12 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















